Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dibenzylamine
2. Dibenzylamine Acetate
3. Dibenzylamine Hydrochloride
1. 494-19-9
2. 10,11-dihydro-5h-dibenzo[b,f]azepine
3. 10,11-dihydro-5h-dibenz[b,f]azepine
4. Iminobibenzyl
5. 2,2'-iminodibenzyl
6. Iminodibenyl
7. 2,2'-iminobibenzyl
8. 5h-dibenz[b,f]azepine, 10,11-dihydro-
9. 6,11-dihydro-5h-benzo[b][1]benzazepine
10. Rp 23669
11. 10,11-dihydrodibenz(b,f)azepine
12. Mfcd00005070
13. Nsc 72110
14. 10,11-dihydro-5-dibenz(b,f)azepine
15. 5h-dibenz(b,f)azepine, 10,11-dihydro-
16. 10,11-dihydro-5h-dibenz(b,f)azepine
17. Chembl63054
18. 262bx7oe3u
19. Clomipramine Hcl Ep Impurity E
20. 10,11-dihydrodibenz[b,f]azepine
21. Nsc-72110
22. Dsstox_cid_29374
23. Dsstox_rid_83489
24. Dsstox_gsid_49414
25. 10,11-dihydro-5h-dibenzo[b,f]azepine (iminodibenzyl)
26. Cas-494-19-9
27. 10,11-dihydro-5h-dibenzo(b,f)azepine
28. Einecs 207-787-1
29. Brn 0152732
30. Unii-262bx7oe3u
31. Iminodibenzyyl
32. Ai3-39165
33. 10,f]azepine
34. Carbamazepine Impurity E
35. Ec 207-787-1
36. Oprea1_136738
37. 5-20-08-00092 (beilstein Handbook Reference)
38. Schembl407439
39. Dtxsid8049414
40. Wln: T C676 Bm&t&j
41. 5h-dibenz[b, 10,11-dihydro-
42. Nsc72110
43. Str02159
44. Zinc1470731
45. Tox21_113758
46. Tox21_202836
47. Bbl011749
48. Bdbm50012879
49. Stk299261
50. Carbamazepine Impurity E [ip]
51. 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene
52. 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene
53. Akos000119140
54. Ac-7238
55. Gf-0137
56. Ncgc00253630-01
57. Ncgc00260382-01
58. 10,11-dihydro-5h-dibenz [b,f]azepine
59. Sy005302
60. 10,11-dihydro-5h-dibenzo[b,f]azepine #
61. 5h-dibenzo[b,f]azepine, 10,11-dihydro-
62. Cs-0020288
63. D0269
64. Carbamazepine Impurity E [ep Impurity]
65. 10,11-dihydro-5h-dibenz(b.f)azepine
66. 10,11-dihydro-5h-dibenz[b,f]azepine, 97%
67. A827711
68. Sr-01000395830
69. J-650002
70. Q-201235
71. Q1096623
72. Sr-01000395830-1
73. Trimipramine Maleate Impurity F [ep Impurity]
74. Iminodibenzyl (10,11-dihydro-5h-dibenzo[b,f]azepine)
75. Z256709566
76. Clomipramine Hydrochloride Impurity E [ep Impurity]
77. Iminodibenzyl, United States Pharmacopeia (usp) Reference Standard
78. Trimipramine Maleate Impurity, Iminodibenzyl-[usp Impurity]
79. Iminodibenzyl, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 195.26 g/mol |
|---|---|
| Molecular Formula | C14H13N |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 195.104799419 g/mol |
| Monoisotopic Mass | 195.104799419 g/mol |
| Topological Polar Surface Area | 12 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 191 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Dibenzylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dibenzylamine manufacturer or Dibenzylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dibenzylamine manufacturer or Dibenzylamine supplier.
PharmaCompass also assists you with knowing the Dibenzylamine API Price utilized in the formulation of products. Dibenzylamine API Price is not always fixed or binding as the Dibenzylamine Price is obtained through a variety of data sources. The Dibenzylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dibenzylamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dibenzylamine, including repackagers and relabelers. The FDA regulates Dibenzylamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dibenzylamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dibenzylamine supplier is an individual or a company that provides Dibenzylamine active pharmaceutical ingredient (API) or Dibenzylamine finished formulations upon request. The Dibenzylamine suppliers may include Dibenzylamine API manufacturers, exporters, distributors and traders.
click here to find a list of Dibenzylamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dibenzylamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Dibenzylamine active pharmaceutical ingredient (API) in detail. Different forms of Dibenzylamine DMFs exist exist since differing nations have different regulations, such as Dibenzylamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dibenzylamine DMF submitted to regulatory agencies in the US is known as a USDMF. Dibenzylamine USDMF includes data on Dibenzylamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dibenzylamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dibenzylamine suppliers with USDMF on PharmaCompass.
Dibenzylamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dibenzylamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dibenzylamine GMP manufacturer or Dibenzylamine GMP API supplier for your needs.
A Dibenzylamine CoA (Certificate of Analysis) is a formal document that attests to Dibenzylamine's compliance with Dibenzylamine specifications and serves as a tool for batch-level quality control.
Dibenzylamine CoA mostly includes findings from lab analyses of a specific batch. For each Dibenzylamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dibenzylamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dibenzylamine EP), Dibenzylamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dibenzylamine USP).
